The decision to exit your business is just the beginning of a complex, high-stakes journey. You have spent years building a successful agency, cultivating a reliable referral network, and providing exceptional patient care. However, when it comes time to transition ownership, buyers will look beyond your top-line revenue; they want to understand and verify every number, process, and patient chart.

In 2026, the home health and hospice mergers and acquisitions landscape is highly disciplined. Buyers have ample capital but deploy it cautiously. They conduct exhaustive due diligence to uncover hidden liabilities and ensure the business can sustain its growth post-close. If your agency is unprepared for this intense scrutiny, you risk delays, reduced valuations, or even a broken deal.

The most effective way to protect your valuation is to conduct pre-sale due diligence. By auditing your own agency before a buyer signs a Letter of Intent (LOI), you can identify and correct issues that might otherwise derail the transaction.

If you are selling a healthcare business this year, preparation is your greatest leverage. Use this comprehensive 2026 pre-sale due diligence checklist to ensure your financial, operational, and compliance processes are in order.

Phase 1: Financial Readiness

Financial due diligence is the backbone of any healthcare transaction. Buyers will scrutinize your profit and loss statements and balance sheets to validate the valuation. When you prepare to list a home health care business for sale, clarity and accuracy in your financials are key.

1. Recast Your Adjusted EBITDA

Buyers base their valuation multiples on your Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization). Recasting or “Adjusting” EBITDA involves adding back personal, non-recurring, or discretionary expenses to show the true profitability of the business under new ownership.

  • Action Step: Document all owner addbacks clearly. This includes items such as personal vehicle leases, one-time legal settlements, excessive owner compensation, or above-market rent paid to an entity you own. Keep a meticulous paper trail justifying every single adjustment.

2. Clean Up Accounts Receivable (AR)

A bloated AR aging report signals collection issues and poor revenue cycle management. Buyers view old debt as a liability.

  • Action Step: Aggressively pursue outstanding payments and write off older debts that you realistically cannot collect. Presenting a clean, current AR balance demonstrates strong internal controls and healthy cash flow.

3. Commissioning a Quality of Earnings (QoE) Report

Sophisticated buyers will undoubtedly perform their own QoE analysis, but some clients will ask if they should commission their own pre-sale QoE report. While it can validate your financial claims upfront, it is a costly and time-consuming process that is generally not necessary for a successful transaction.

  • Action Step: While commissioning an independent pre-sale financial QoE report can be beneficial, you should consult an experienced M&A advisory firm to discuss what is in your best interests.

4. Organize Tax and Payroll Records

Buyers want assurance that you have paid all local, state, and federal taxes properly and that your employee classification is legally sound.

  • Action Step: Gather the last three to five years of corporate tax returns and ensure all W-2s and 1099s are categorized correctly. Misclassifying caregivers as independent contractors when they should be employees is a massive red flag for buyers.

Phase 2: Operational Documentation

A profitable business is only attractive if those profits are sustainable. Buyers need proof that the agency functions smoothly and can scale without your daily intervention.

1. Document Key Performance Indicators (KPIs)

Buyers love data. They want to see trends regarding your patient census, referral sources, and cost per visit.

  • Action Step: Compile rolling 12-month reports on your most critical metrics. Highlight your patient admission rates, average length of stay, and referral source diversification. Also, it’s generally beneficial to broaden your referral base; if a high percentage of your clients come from a single referral source, buyers may view that concentration as a potential risk.

2. Outline Payer Mix and Contracts

In 2026, payer mix heavily influences valuation. Heavy reliance on lower-paying Medicare Advantage plans can impact your valuation, while a healthy blend of traditional Medicare and episodic commercial payors is highly desirable.

  • Action Step: Assemble a centralized folder of all active payor contracts and review the assignment clauses to understand what happens to these contracts during a change of ownership (CHOW).

3. Evaluate Staffing and Retention

When listing a home health agency for sale, your administrative and clinical teams are one of your most valuable assets. High turnover rates suggest cultural issues and introduce severe operational risk for the new owner.

  • Action Step: Document your organizational chart, noting key leadership roles and their tenure. Calculate your caregiver retention rates and compare them to industry benchmarks. Highlight any specific training or retention programs you have implemented.

4. Audit Your Technology Infrastructure

Modern buyers expect modern solutions. Heavy reliance on paper charting or outdated legacy software requires immediate capital expenditure from the buyer to fix, which can impact interest level and valuation.

  • Action Step: Outline your current tech stack, including your Electronic Medical Record (EMR) system, billing software, and telehealth platforms.

Phase 3: Legal and Compliance Security

In the highly regulated healthcare sector, compliance is essential. A buyer can fix an operational inefficiency, but a major regulatory violation can suspend a deal instantly.

1. Verify Licensure and Certifications

Having missing or expired licenses is problematic and will trigger regulatory scrutiny.

  • Action Step: Create a master spreadsheet tracking all state licenses, Medicare/Medicaid provider numbers, National Provider Identifier (NPI) numbers, and accreditation certificates (such as CHAP or ACHC).

2. Conduct Clinical Chart Audits

Clinical due diligence terrifies many sellers, but it doesn’t have to. Buyers will pull a random sample of patient charts to ensure you bill properly and document care accurately. Preparation will improve your odds of success and minimize surprises.

  • Action Step: Perform internal mock audits on your active and discharged patient charts. Ensure every file has a signed plan of care (485), documented face-to-face encounters, compliant visit verification logs, and proper physician signatures. Fix minor administrative errors and ensure proper procedures.

3. Review Corporate and Legal Documents

The buyer’s legal team will comb through your corporate history to ensure the entity they are buying is structurally sound and free of pending litigation.

  • Action Step: Gather your Articles of Incorporation, operating agreements, and capitalization tables. Disclose any past or pending lawsuits, labor disputes, or regulatory investigations upfront. Transparency builds trust; hidden surprises destroy it.

4. Assess HIPAA and Cybersecurity Protocols

Data breaches are incredibly costly and damage patient trust. Buyers want to know your patient data is secure.

  • Action Step: Document your HIPAA compliance policies. Ensure you have Business Associate Agreements (BAAs) on file for all third-party vendors. Conduct a cybersecurity risk assessment to confirm that your systems protect sensitive Protected Health Information (PHI).

Maximize Your Value with Expert Guidance

While the foregoing pre-sale due diligence list outlines many of the items for an owner to focus on prior to engaging buyers, each circumstance is unique and requires a different level of attention. Therefore, it’s imperative to consult with an experienced M&A advisor sooner than later to discuss your specific situation.

Navigating pre-sale due diligence requires significant time, energy, and specialized knowledge. Taking your eye off the daily operations of your business to focus on a sale can cause your numbers to dip right when you need them to peak.

However, you don’t have to manage this complex process alone. Working with an experienced M&A advisor ensures your agency is packaged perfectly for the market, mitigating risks and driving up competitive bids.

At Stoneridge Partners, we specialize exclusively in healthcare M&A. We understand exactly what buyers are looking for in 2026 and how to position your agency for a premium valuation. We guide you through every step of the process, from recasting your financials to navigating the final closing documents.

Ready to prepare your business for a successful exit? Contact Stoneridge Partners today for a confidential strategy meeting and let us help you secure the legacy and financial reward you deserve.

Ben B

Ben Bogan, J.D., Partner and Managing Director at Stoneridge Partners, has been a leading figure in healthcare M&A since 2014, specializing in home health, home care, and hospice transactions. With over 70 successful closed deals, Ben’s experience and expertise have set him apart as a skilled and invaluable intermediary in the industry.
 
With a law degree from Albany Law School, a BSBA in Economics from the University of Florida, and his background as a former Assistant District Attorney and Assistant District Counsel for the U.S. Army Corps of Engineers, Ben combines his legal background and M&A expertise to deliver exceptional results in every transaction. Available to his clients 24/7, Ben builds strong relationships with his clients and has garnered rave reviews.

For more information, please contact Ben directly at 520-991-4653 or [email protected]. All communications are confidential.